Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation

NCT00628394 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

119

Enrollment

OTHER

Sponsor class

Conditions

Cognition in Schizophrenia

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]